Polyglutamine diseases: a transcription disorder?

Area of Science:

• Molecular biology
• Neuroscience
• Genetics

Background:

• Polyglutamine diseases are linked to expanded polyglutamine proteins affecting cellular functions.
• These proteins interfere with critical molecular processes such as unfolded protein response, protein transport, synaptic transmission, and transcription.
• Over 20 transcription factors interact with disease proteins, leading to repressed gene expression.

Purpose of the Study:

• To review the 'transcription theory' concerning polyglutamine diseases.
• To elucidate the nuclear events triggered by disease-associated proteins.
• To connect findings on transcription factors with the nature of nuclear bodies and inclusion bodies.

Main Methods:

• Literature review of studies on polyglutamine diseases.
• Analysis of molecular mechanisms involving expanded polyglutamine proteins.
• Examination of interactions between disease proteins and transcription factors.

Main Results:

• Expanded polyglutamine proteins significantly impact gene expression through interactions with transcription factors.
• Nuclear events, including the formation of inclusion bodies, are increasingly understood in relation to these interactions.
• A growing body of evidence supports the 'transcription theory' as a key aspect of polyglutamine disease pathology.

Conclusions:

• Transcription dysregulation is a central mechanism in polyglutamine diseases.
• Understanding nuclear events and protein interactions is crucial for deciphering disease pathogenesis.
• The 'transcription theory' offers a unifying framework for polyglutamine disease research.